Host-derived mannose glycans trigger a pathogenic γδ T cell/IL-17a axis in autoimmunity
Science Translational Medicine · 2023
DOI: 10.1126/scitranslmed.abo1930 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, 2023. Verfasst von Inês Alves und 18 weiteren Autor:innen. Beteiligte Einrichtung: i3s - Institute for Research and Innovation in Health, University of Porto, 4200-135 Porto, Portugal. Hauptthemen laut MEDLINE: Autoimmune Diseases, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Autoimmune diseases are life-threatening disorders that cause increasing disability over time. Systemic lupus erythematosus (SLE) and other autoimmune diseases arise when immune stimuli override mechanisms of self-tolerance. Accumulating evidence has demonstrated that protein glycosylation is substantially altered in autoimmune disease development, but the mechanisms by which glycans trigger these autoreactive immune responses are still largely unclear. In this study, we found that presence of microbial-associated mannose structures at the surface of the kidney triggers the recognition of DC-SIGN–expressing γδ T cells, inducing a pathogenic interleukin-17a (IL-17a)–mediated autoimmune response. Mice lacking Mgat5 , which have a higher abundance of mannose structures in the kidney, displayed increased γδ T cell infiltration into the kidney that was associated with spontaneous development of lupus in older mice. N -acetylglucosamine supplementation, which promoted biosynthesis of tolerogenic branched N-glycans in the kidney, was found to inhibit γδ T cell infiltration and control disease development. Together, this work reveals a mannose–γδ T cell–IL-17a axis in SLE immunopathogenesis and highlights glycometabolic reprogramming as a therapeutic strategy for autoimmune disease treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- i3s - Institute for Research and Innovation in Health, University of Porto, 4200-135 Porto, Portugal.
- Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.
- Glycosystems Laboratory, Instituto de Investigaciones Químicas (IIQ), CSIC - Universidad de Sevilla, 41092 Sevilla, Spain.
- ICBAS-School of Medicine and Biomedical Sciences, University of Porto, 4050-313 Porto, Portugal.
- Department of Clinical Immunology, Centro Hospitalar Universitário do Porto, 4099-001 Porto, Portugal.
- Nephrology Department, Centro Hospitalar e Universitário do Porto, 4099-001 Porto, Portugal.
ORCID-Profile: Inês Alves, Beatriz Santos-Pereira, Noelia de la Cruz, Ana Campar, Vanda Pinto, Pedro M Rodrigues, Marco Araújo, Sofia Santos, Javier Ramos-Soriano, Carlos Vasconcelos, Roberto Silva, Filipe Mira, Cristina C Barrias, Nuno L Alves, Lélita Santos, António Marinho, Salomé S Pinho
Zitieren
APA
Alves, I., Santos-Pereira, B., de la Cruz, N., Campar, A., Pinto, V., Rodrigues, P. M., Araújo, M., Santos, S., Ramos-Soriano, J., Vasconcelos, C., Silva, R., Afonso, N., Mira, F., Barrias, C. C., Alves, N. L., Rojo, J., Santos, L., Marinho, A., & Pinho, S. S. (2023). Host-derived mannose glycans trigger a pathogenic γδ T cell/IL-17a axis in autoimmunity. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.abo1930
Vancouver
Alves I, Santos-Pereira B, de la Cruz N, Campar A, Pinto V, Rodrigues PM, et al. Host-derived mannose glycans trigger a pathogenic γδ T cell/IL-17a axis in autoimmunity. Science Translational Medicine. 2023. doi:10.1126/scitranslmed.abo1930
BibTeX
@article{Alves2023,
author = {Alves, Inês and Santos-Pereira, Beatriz and de la Cruz, Noelia and Campar, Ana and Pinto, Vanda and Rodrigues, Pedro M and Araújo, Marco and Santos, Sofia and Ramos-Soriano, Javier and Vasconcelos, Carlos and Silva, Roberto and Afonso, Nuno and Mira, Filipe and Barrias, Cristina C and Alves, Nuno L and Rojo, Javier and Santos, Lélita and Marinho, António and Pinho, Salomé S},
title = {Host-derived mannose glycans trigger a pathogenic γδ T cell/IL-17a axis in autoimmunity},
journal = {Science Translational Medicine},
year = {2023},
doi = {10.1126/scitranslmed.abo1930}
}
EUVIMED